
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
AdvisorShares Pure US Cannabis ETF (MSOS)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: MSOS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit -38.78% | Avg. Invested days 18 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) - | Beta 1.16 | 52 Weeks Range 2.02 - 8.19 | Updated Date 06/30/2025 |
52 Weeks Range 2.02 - 8.19 | Updated Date 06/30/2025 |
Upturn AI SWOT
AdvisorShares Pure US Cannabis ETF
ETF Overview
Overview
The AdvisorShares Pure US Cannabis ETF (MSOS) is an actively managed ETF focused on investing in US cannabis companies, including multi-state operators (MSOs). It seeks capital appreciation by investing primarily in domestic cannabis equity securities.
Reputation and Reliability
AdvisorShares is known for its actively managed ETFs, particularly those focused on niche sectors. Their reputation is tied to the performance of their active strategies.
Management Expertise
The management team has experience in active portfolio management and specialized knowledge of the cannabis industry.
Investment Objective
Goal
To seek long-term capital appreciation by investing in the US cannabis industry.
Investment Approach and Strategy
Strategy: Actively managed, focusing on companies that derive a significant portion of their revenue from the US cannabis industry.
Composition Primarily holds equity securities of US cannabis companies, including MSOs, cultivation, retail, and ancillary businesses.
Market Position
Market Share: MSOS holds a significant market share in the US cannabis ETF segment, reflecting investor interest in direct US cannabis exposure.
Total Net Assets (AUM): 78170000
Competitors
Key Competitors
- TLRY
- YOLO
- MJ
- CNBS
Competitive Landscape
The cannabis ETF market is competitive, with several ETFs offering exposure to various segments of the cannabis industry. MSOS's focus on US-only companies is a key differentiator, providing more direct exposure to the US market. Competitors may offer broader global exposure, including Canadian companies, which presents different risk/reward profiles.
Financial Performance
Historical Performance: Historical performance varies depending on market conditions, regulatory changes, and company performance. Returns have been volatile due to the evolving nature of the cannabis industry.
Benchmark Comparison: No specific benchmark index. Performance should be compared to a broad market index and similar US cannabis-focused funds to gauge effectiveness.
Expense Ratio: 0.74
Liquidity
Average Trading Volume
MSOS typically exhibits a relatively high average trading volume, indicating strong liquidity.
Bid-Ask Spread
The bid-ask spread is generally tight, indicating efficient trading and lower transaction costs.
Market Dynamics
Market Environment Factors
Regulatory changes, state-level legalization, consumer demand, and political sentiment heavily influence the performance of US cannabis companies.
Growth Trajectory
The growth trajectory is closely linked to the expansion of legal cannabis markets across US states and potential federal regulatory reform. Strategy and holdings remain relatively consistent, focusing on pure-play US cannabis companies.
Moat and Competitive Advantages
Competitive Edge
MSOS's primary advantage is its focus on US-only cannabis companies, which allows investors to directly benefit from the growth of the US market. Its active management approach allows for adjustments based on market dynamics and company-specific factors. The fund also offers a purer play on the US cannabis theme compared to globally diversified cannabis ETFs. It capitalizes on multi-state operators and other domestic cannabis businesses.
Risk Analysis
Volatility
MSOS exhibits high volatility due to the nascent stage and regulatory uncertainty surrounding the cannabis industry.
Market Risk
Specific risks include regulatory risks (changes in legalization status), market competition, financial risks (access to capital), and social acceptance risks.
Investor Profile
Ideal Investor Profile
Aggressive growth investors with a high-risk tolerance who are optimistic about the future of the US cannabis industry and are willing to accept volatility.
Market Risk
Best suited for long-term investors with a high-risk appetite seeking capital appreciation rather than income.
Summary
MSOS is an actively managed ETF focused on the US cannabis market, offering concentrated exposure to companies operating within the sector. It carries a higher degree of risk and volatility compared to broader market ETFs. Ideal investors should have a long-term horizon, be risk-tolerant, and bullish on the growth of the US cannabis market. The ETF's performance is highly dependent on regulatory developments and market sentiment towards cannabis. Its active management aims to provide a competitive edge in this rapidly evolving industry.
Peer Comparison
Sources and Disclaimers
Data Sources:
- AdvisorShares Website
- ETF.com
- Bloomberg
- Morningstar
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Investors should conduct their own due diligence before making any investment decisions. Market share data is approximate and based on available information as of the current date.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AdvisorShares Pure US Cannabis ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.